Egypt vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Egypt
100.0%
in 2024
Sur
82.0%
in 2024
Egypt rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Egypt
- Sur
How they compare
Egypt currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Egypt's figure about 1.2 times Sur's.
Across all 17 years both countries report, Egypt has been ahead every year.
Egypt ranks 1st and Sur ranks 2nd of 144 countries.
Egypt has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Egypt | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 41.0% | 59.0% | Egypt |
| 2010s | 100.0% | 66.3% | 33.7% | Egypt |
| 2020s | 100.0% | 75.8% | 24.2% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Egypt or Sur?
- Egypt, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Egypt and Sur?
- 18.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Sur?
- 17 years are reported by both, from 2008 to 2024.
- How do Egypt and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Egypt ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.